Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: concept to treatment. J Hepatol 2015;62:S15-24. https://doi.org/10.1016/j.jhep.2015.02.039.

Article  CAS  PubMed  Google Scholar 

Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 2021;18:151–166. https://doi.org/10.1038/s41575-020-00372-7.

Article  PubMed  Google Scholar 

Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655–1669. https://doi.org/10.1053/j.gastro.2008.03.003.

Article  CAS  PubMed  Google Scholar 

Wang S, Friedman SL. Found in translation—fibrosis in metabolic dysfunction–associated steatohepatitis (MASH). Sci Transl Med 2023;15:eadi0759. https://doi.org/10.1126/scitranslmed.adi0759.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horn P, Tacke F. Metabolic reprogramming in liver fibrosis. Cell Metab 2024;36:1439–1455. https://doi.org/10.1016/j.cmet.2024.05.003.

Article  CAS  PubMed  Google Scholar 

Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol 2023;79:516–537. https://doi.org/10.1016/j.jhep.2023.03.017.

Article  PubMed  Google Scholar 

Lackner C, Tiniakos D. Fibrosis and alcohol-related liver disease. J Hepatol 2019;70:294–304. https://doi.org/10.1016/j.jhep.2018.12.003.

Article  PubMed  Google Scholar 

Khomich O, Ivanov AV, Bartosch B. Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells 2019;9:24. https://doi.org/10.3390/cells9010024.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 2017;14:397–411. https://doi.org/10.1038/nrgastro.2017.38.

Article  CAS  PubMed  Google Scholar 

Cogliati B, Yashaswini CN, Wang S, Sia D, Friedman SL. Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat Rev Gastroenterol Hepatol 2023;20:647–661. https://doi.org/10.1038/s41575-023-00821-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut 2015;64:830–841. https://doi.org/10.1136/gutjnl-2014-306842.

Article  CAS  PubMed  Google Scholar 

Zhong G, Kirkwood J, Won K-J, Tjota N, Jeong H, Isoherranen N. Characterization of vitamin A metabolome in human livers with and without nonalcoholic fatty liver disease. J Pharmacol Exp Ther 2019;370:92–103. https://doi.org/10.1124/jpet.119.258517.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev 2021;176:113869. https://doi.org/10.1016/j.addr.2021.113869.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gandhi CR. Hepatic stellate cell activation and pro-fibrogenic signals. J Hepatol 2017;67:1104–1105. https://doi.org/10.1016/j.jhep.2017.06.001.

Article  PubMed  PubMed Central  Google Scholar 

Kamm DR, McCommis KS. Hepatic stellate cells in physiology and pathology. J Physiol 2022;600:1825–1837. https://doi.org/10.1113/JP281061.

Article  CAS  PubMed  Google Scholar 

Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 2021;184:2537–2564. https://doi.org/10.1016/j.cell.2021.04.015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 2019;65:37–55. https://doi.org/10.1016/j.mam.2018.09.002.

Article  CAS  PubMed  Google Scholar 

Shalimar, Kumar D, Vadiraja PK, Nayak B, Thakur B, Das P et al. Acute on chronic liver failure because of acute hepatic insults: etiologies, course, extrahepatic organ failure and predictors of mortality. J Gastroenterol Hepatol 2016;31:856–64. https://doi.org/10.1111/jgh.13213.

Article  CAS  PubMed  Google Scholar 

Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 2017;121:27–42. https://doi.org/10.1016/j.addr.2017.05.007.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 2013;4:2823. https://doi.org/10.1038/ncomms3823.

Article  CAS  PubMed  Google Scholar 

Fedele M, Benvenuto G, Pero R, Majello B, Battista S, Lembo F et al. A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J Biol Chem 2000;275:7894–7901. https://doi.org/10.1074/jbc.275.11.7894.

Article  CAS  PubMed  Google Scholar 

Piepoli S, Alt AO, Atilgan C, Mancini EJ, Erman B. Structural analysis of the PATZ1 BTB domain homodimer. Acta Crystallogr D Struct Biol 2020;76:581–593. https://doi.org/10.1107/S2059798320005355.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andersen L, Gülich AF, Alteneder M, Preglej T, Orola MJ, Dhele N et al. The transcription factor MAZR/PATZ1 regulates the development of FOXP3+ regulatory T cells. Cell Rep 2019;29:4447–59.e6. https://doi.org/10.1016/j.celrep.2019.11.089.

Article  CAS  PubMed  Google Scholar 

Pan T, Li J, Zhang O, Zhu Y, Zhou H, Ma M et al. Knockdown of ribosome RNA processing protein 15 suppresses migration of hepatocellular carcinoma through inhibiting PATZ1-associated LAMC2/FAK pathway. BMC Cancer 2024;24:334. https://doi.org/10.1186/s12885-024-12065-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng ZL, Siew J, Li J, Ji G, Huang M, Liao X et al. PATZ1 (MAZR) co-occupies genomic sites with p53 and inhibits liver cancer cell proliferation via regulating p27. Front Cell Dev Biol 2021;9:586150. https://doi.org/10.3389/fcell.2021.586150.

Article  PubMed  PubMed Central  Google Scholar 

Alhalabi KT, Stichel D, Sievers P, Peterziel H, Sommerkamp AC, Sturm D et al. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum. Acta Neuropathol 2021;142:841–857. https://doi.org/10.1007/s00401-021-02354-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho JH, Kim MJ, Kim KJ, Kim JR. POZ/BTB and AT-hook-containing zinc finger protein 1 (PATZ1) inhibits endothelial cell senescence through a p53 dependent pathway. Cell Death Differ 2012;19:703–712. https://doi.org/10.1038/cdd.2011.142.

Article  CAS  PubMed  Google Scholar